Gene-editing therapy Casgevy has been approved for over a year in treating sickle cell disease and transfusion-dependent beta-thalassemia. Sure, it only generated revenue of $8 million in the ...

Along with partner Vertex Pharmaceuticals, it has won regulatory approval for Casgevy, a revolutionary treatment for SCD and beta-thalassemia. Meanwhile, Intellia is partnered with Regeneron ...

Robert “Robin” Wilkin, 66, was thrown off the Sliabh Liag/Slieve League cliffs on June 25 2023. Alan Vial, 39, of Drumanoo Head in Killybegs, and Nikita Burns, 24, from An Charraig in Co Donegal, were ...

Maintaining optimal health and wellness is more important than ever in today’s fast-paced world. As individuals become increasingly aware of the impact of lifestyle choices on their overall well-being ...

It was the first company to receive FDA approval, in December 2023, for Casgevy – a genome-edited cell therapy for sickle-cell disease and another blood disorder, beta thalassaemia. These are ...

Or take Casgevy, the first CRISPR-approved medicine developed by Vertex and CRISPR Therapeutics and approved in December 2023. Critical to the development of the fetal hemoglobin switching ...

The date was Friday, Jan. 31, 2025. It started like any other day. As I settled down to start working, I noticed I had a lot of messages, and more came in as the day went on. Message after message, ...

CRISPR Therapeutics, a pioneering biotechnology company specializing in gene-editing therapeutics, showcased strong momentum in late 2023 with the approval of Casgevy, its groundbreaking treatment for ...

CRISPR Therapeutics, a pioneering biotechnology company specializing in gene-editing therapeutics, showcased strong momentum in late 2023 with the approval of Casgevy, its groundbreaking treatment ...